Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Sep 26, 2014; 6(9): 959-967
Published online Sep 26, 2014. doi: 10.4330/wjc.v6.i9.959
Published online Sep 26, 2014. doi: 10.4330/wjc.v6.i9.959
Ventricular tachycardia mapping and ablation in arrhythmogenic right ventricular cardiomyopathy/dysplasia: Lessons Learned
Cory M Tschabrunn, Harvard-Thorndike Electrophysiology Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, United States
Francis E Marchlinski, Cardiac Electrophysiology Program, Hospital of the University of Pennsylvania, Philadelphia, PA 19102, United States
Author contributions: Tschabrunn CM wrote the manuscript; Marchlinski FE reviewed and edited the manuscript.
Supported by Research funding from Biosense Webster, Inc., to Marchlinski FE
Correspondence to: Francis E Marchlinski, MD, Cardiac Electrophysiology Program, Hospital of the University of Pennsylvania, Founders 9 Pavilion, Philadelphia, PA 19102, United States. francis.marchlinski@uphs.upenn.edu
Telephone: +1-215-6626005 Fax: +1-215-6622879
Received: January 28, 2014
Revised: June 25, 2014
Accepted: July 12, 2014
Published online: September 26, 2014
Processing time: 243 Days and 0.9 Hours
Revised: June 25, 2014
Accepted: July 12, 2014
Published online: September 26, 2014
Processing time: 243 Days and 0.9 Hours
Core Tip
Core tip: This review article evaluates seminal insights derived from the electrophysiology laboratory and the lessons learned to develop a methodical approach that can utilized to successfully perform ventricular tachycardia ablation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.